UNSPSC 51452800: Anthelmintic macrolides

Anthelmintic drugs made from a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone.

UNSPSC 51452800 Anthelmintic macrolides is a Class code covering pharmaceutical products purchased by state and local health departments and county public health agencies, though the recent opportunities tagged under this code show limited alignment with the nominal category name. State and local governments use this code to procure both antiparasitic pharmaceuticals and, as evidenced by recent awards, broader pharmaceutical inventory including antibiotics and emergency medical supplies. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets with a 12-month initial term and renewal options through year three. Issuing bodies include state health departments and county health agencies; the Illinois Department of Public Health (Mike Caceres, 217-577-7905) is a documented repeat buyer under related cooperative purchasing vehicles.

Activity appears concentrated in Florida and Illinois. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the response deadline was July 26, 2023, and the contract carried a two-year initial term with a one-year renewal option. While the Seminole County solicitation and Illinois award both carry UNSPSC 51452800 tags, they represent pharmaceutical procurement spanning antibiotics, emergency reversal agents, and drug-disposal systems rather than anthelmintic products specifically, suggesting the code may serve as a catch-all for state and local pharmaceutical purchasing outside dedicated therapeutic categories. Vendors should verify code applicability during pre-bid outreach, as misalignment between nominal scope and actual acquisitions creates scoring risk in responsive-bid evaluation.